Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-14, with 91 holding rows worth $333,168,000.

Accession
0001521536-14-000049
Filed
2014-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 91 entries on the cover page, a total value of $333,168,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $333,168,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Gilead Sciences,Inc.375558103COM248,735$17,625,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM111,731$16,998,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock55,792$16,753,000thousands by filing date
BIOGEN INC COM09062X103Stock41,048$12,555,000thousands by filing date
Pfizer Inc.717081103COM352,989$11,338,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM145,264$9,908,000thousands by filing date
PHARMACYCLICS INC716933106COM97,286$9,750,000thousands by filing date
ALKERMES PLCG01767105SHS201,277$8,874,000thousands by filing date
CELGENE CORP151020104COM58,391$8,151,000thousands by filing date
MEDIVATION INC58501N101COM104,505$6,727,000thousands by filing date
CVS Health Corporation126650100COM88,442$6,621,000thousands by filing date
INCYTE CORP COM45337C102Stock107,038$5,729,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR107,922$5,703,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM53,788$5,573,000thousands by filing date
Actavis Plc30083B108SHS25,498$5,249,000thousands by filing date
CARDINAL FINANCIAL CORP14149F109COMMON STOCK71,909$5,032,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM166,970$4,997,000thousands by filing date
Johnson & Johnson478160104COM50,000$4,912,000thousands by filing datecall
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK265,325$4,521,000thousands by filing date
FOREST LABS INC345838106COM48,152$4,443,000thousands by filing date
AbbVie,Inc.00287Y109COM85,494$4,394,000thousands by filing date
Merck & Co.,Inc.58933Y105COM76,650$4,351,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM176,883$4,304,000thousands by filing date
Stryker Corporation863667101COM51,100$4,163,000thousands by filing date
CYBERONICS23251P102COMMON STOCK63,754$4,160,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM34,394$4,136,000thousands by filing date
CIGNA CORPORATION125509109COM49,135$4,114,000thousands by filing date
Amgen Inc.031162100COM46,135$3,950,000thousands by filing date
Boston Scientific Corporation101137107COM284,978$3,853,000thousands by filing date
HCA Healthcare Inc40412C101COM70,262$3,689,000thousands by filing date
CATAMARAN CORP148887102COM80,880$3,620,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock46,187$3,426,000thousands by filing date
ALLERGAN INC018490102COM27,516$3,415,000thousands by filing date
NUVASIVE INC670704105COM88,442$3,397,000thousands by filing date
DEXCOM INC COM252131107Stock78,788$3,259,000thousands by filing date
COVIDIEN PLCG2554F113SHS44,221$3,257,000thousands by filing date
Bristol-Myers Squibb Company110122108COM86,815$3,178,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM68,395$3,154,000thousands by filing date
Eli Lilly and Company532457108COM53,458$3,147,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock47,169$2,936,000thousands by filing date
UnitedHealth Group Inc91324P102COM62,979$2,854,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM37,834$2,841,000thousands by filing date
INSULET CORP COM45784P101Stock58,961$2,796,000thousands by filing date
MCKESSON CORP COM58155Q103Stock26,620$2,770,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK68,788$2,694,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW39,567$2,661,000thousands by filing date
PAREXEL INTL CORP699462107COM49,135$2,658,000thousands by filing date
ENDOLOGIX INC29266S106COM201,843$2,598,000thousands by filing date
THORATEC CORP885175307COM68,788$2,463,000thousands by filing date
MEDTRONIC INC585055106COM39,429$2,426,000thousands by filing date
OMNICARE INC681904108COM39,308$2,346,000thousands by filing date
ABIOMED INC003654100COM89,916$2,341,000thousands by filing date
ST JUDE MED INC790849103COM34,394$2,249,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM1,228,354$2,211,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM181,797$2,203,000thousands by filing date
RITEAID CORP767754104COM344,805$2,162,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK329,199$2,140,000thousands by filing date
WELLPOINT INC94973V107COM40,000$2,130,000thousands by filing date
VARIAN MED SYS INC92220P105COM34,000$2,036,000thousands by filing date
CEPHEID15670R107COM39,308$2,028,000thousands by filing date
BAXTER INTL INC071813109COM42,169$1,984,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM237,810$1,917,000thousands by filing date
Johnson & Johnson478160104COM19,481$1,914,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM73,702$1,902,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK98,269$1,787,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM196,537$1,757,000thousands by filing date
MASIMO CORP COM574795100Stock63,875$1,744,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK63,875$1,736,000thousands by filing date
ENDOCYTE INC29269A102COM68,788$1,638,000thousands by filing date
CENCORA INC COM03073E105Stock35,000$1,637,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock19,654$1,613,000thousands by filing date
BECTON DICKINSON & CO075887109COM24,000$1,586,000thousands by filing date
CAREFUSION CORP14170T101COM39,308$1,581,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM49,135$1,548,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock329,199$1,547,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM73,702$1,302,000thousands by filing date
TROVAGENE INC897238309COM196,537$1,126,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK73,702$1,100,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM132,766$1,094,000thousands by filing date
EXELIXIS INC COM30161Q104Stock294,805$1,044,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW147,403$974,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW196,537$936,000thousands by filing date
VOLCANO CORPORATION928645100COM44,221$872,000thousands by filing date
MYRIAD GENETICS INC62855J104COM24,568$840,000thousands by filing date
BIND THERAPEUTICS INC05548N107Cmn60,000$718,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock20,047$653,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK49,135$630,000thousands by filing date
MACROGENICS INC556099109COM20,000$557,000thousands by filing date
NEWLINK GENETICS CORP651511107COM19,605$557,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872104COM294,805$510,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares117,922$395,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001521536-14-000049this filing2014-05-14acceptance time not in the bulk data set